Physician profile
Albert Kim
NPI 1780682583
$3,382.97
in general payments reported to CMS, 2019-2025
23 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $649 · 2021: $531 · 2022: $520 · 2023: $577 · 2024: $413 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,159.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $615.75 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $418.96 | 2021-2024 | Verquvo, Steglatro, Lagevrio |
| E.R. Squibb & Sons, L.L.C. | $344.00 | 2019-2024 | Camzyos, Eliquis |
| Pfizer INC. | $306.04 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $280.62 | 2020-2023 | Farxiga |
| Amgen INC. | $280.04 | 2019-2025 | Repatha, Repatha |
| Abiomed | $166.49 | 2019-2025 | Impella |
| Sanofi-Aventis U.S. LLC | $165.68 | 2020-2023 | |
| Amarin Pharma, INC. | $164.98 | 2020-2023 | |
| Boston Scientific Corporation | $136.66 | 2019-2024 | Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.10 | 2019 | |
| Chiesi USA, INC. | $75.13 | 2021 | |
| Astellas Pharma US INC | $65.06 | 2019-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $56.10 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $40.71 | 2023-2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $39.79 | 2020 | |
| Arbor Pharmaceuticals, INC. | $23.77 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $23.54 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.98 | 2019 | |
| Ani Pharmaceuticals, INC. | $17.56 | 2024 | Purified Cortrophin Gel |
| Livanova USA, INC. | $15.68 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.84 | 2025 | |
| Medtronic, INC. | $14.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.